A detailed history of City State Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, City State Bank holds 3,286 shares of LLY stock, worth $2.71 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
3,286
Previous 3,127 5.08%
Holding current value
$2.71 Million
Previous $2.77 Million 8.45%
% of portfolio
0.9%
Previous 1.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$727.2 - $932.06 $115,624 - $148,197
159 Added 5.08%
3,286 $2.54 Million
Q3 2024

Oct 10, 2024

SELL
$772.14 - $960.02 $78,758 - $97,922
-102 Reduced 3.16%
3,127 $2.77 Million
Q2 2024

Jul 08, 2024

SELL
$724.87 - $909.04 $11,597 - $14,544
-16 Reduced 0.49%
3,229 $2.92 Million
Q1 2024

Apr 11, 2024

SELL
$592.2 - $792.28 $120,216 - $160,832
-203 Reduced 5.89%
3,245 $2.52 Million
Q4 2023

Jan 10, 2024

SELL
$525.19 - $619.13 $76,152 - $89,773
-145 Reduced 4.04%
3,448 $2.01 Million
Q3 2023

Oct 16, 2023

SELL
$434.7 - $599.3 $76,072 - $104,877
-175 Reduced 4.64%
3,593 $1.93 Million
Q2 2023

Jul 10, 2023

SELL
$350.74 - $468.98 $8,067 - $10,786
-23 Reduced 0.61%
3,768 $1.77 Million
Q1 2023

Apr 10, 2023

SELL
$310.63 - $364.82 $37,275 - $43,778
-120 Reduced 3.07%
3,791 $1.3 Million
Q4 2022

Jan 11, 2023

SELL
$321.55 - $374.67 $124,118 - $144,622
-386 Reduced 8.98%
3,911 $1.43 Million
Q3 2022

Oct 24, 2022

SELL
$296.48 - $337.87 $12,748 - $14,528
-43 Reduced 0.99%
4,297 $1.39 Million
Q2 2022

Aug 22, 2022

BUY
$278.73 - $327.27 $6,968 - $8,181
25 Added 0.58%
4,340 $1.41 Million
Q1 2022

Jun 01, 2022

BUY
$234.69 - $291.66 $13,377 - $16,624
57 Added 1.34%
4,315 $1.24 Million
Q4 2021

Mar 23, 2022

BUY
$224.85 - $279.04 $9,668 - $11,998
43 Added 1.02%
4,258 $1.18 Million
Q4 2021

Mar 11, 2022

BUY
$224.85 - $279.04 $947,742 - $1.18 Million
4,215 New
4,215 $1.11 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $782B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track City State Bank Portfolio

Follow City State Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.